Analysis indicates that despite Tilray Brands' record net revenue for fiscal year 2026, a "buy" recommendation is not advised due to cash consumption and poor stock performance.

Yahoo Finance reported that cannabis company Tilray Brands (NASDAQ: TLRY) achieved a record-high net income of $915.5 million in fiscal year 2026, an 11% year-over-year increase. However, analysis suggests that the company's growth was primarily driven by high-cost acquisitions and international expansion. Furthermore, over the past 12 months, the company consumed $69 million in cash from operating activities and $56 million from investing activities. Additionally, Tilray's stock price has fallen by 97% over the past five years, leading to a recommendation against investors purchasing the stock.